ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Italfarmaco clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 51 studies whose lead sponsor is Italfarmaco or one of 3 companies grouped under it. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2026.

Our grouping of 5 registry names, not the registry’s. See them and correct one ↓

Compare Italfarmaco with Sarepta Therapeutics and Novartis →

Pipeline: 2 programs

Each counted once: 2 with a study Italfarmaco leads registered in the last two years.

  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Italfarmaco’s own registered studies; Italfarmaco’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Italfarmaco’s studies test, most open studies first — 6 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

4 of Italfarmaco’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. 2F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 4 to your calendar (.ics) → With an account.

All 51 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1122%Recruiting 7 · Not yet recruiting 4
  • Under way, not recruiting12%
  • Completed3161%
  • Stopped early612%
  • Status unknown or other24%

Phase

  • Phase 216
  • Phase 112
  • Phase 36
  • Phase 42

Where

  • Italy26
  • Spain16
  • Netherlands8
  • France8
  • United Kingdom8
  • Romania7

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 726

By the year each study started; 2 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Italfarmaco.

  • Italfarmaco
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    35 studies
  • Lacer S.A.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies →
  • ITF Therapeutics LLC
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Effik
    Acquired — became part of Italfarmaco, Sep 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Italfarmaco S.A
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 →